Lupin’s European Arm Acquires Sanofi Brands to Boost Respiratory and Gastro-Intestinal Portfolio, Shares Rise 3.21%

Drug maker Lupin announced that its European arm has finalized the acquisition of two brands from Sanofi. Lupin Atlantis Holdings SA has acquired Aarane in Germany and Nalcrom in Canada and the Netherlands, along with the associated trademark rights. This acquisition aligns with Lupin’s strategy to expand its global presence in specialty areas. The acquisition is expected to bolster Lupin’s respiratory business in Germany and enhance its portfolio of branded products for treating diverse respiratory diseases and conditions, as well as gastro-intestinal care. Shares of Lupin were trading 3.21% higher at Rs 1,613.45 apiece on the BSE.